Home/Filings/4/0001931406-23-000002
4//SEC Filing

Sikri Vishal 4

Accession 0001931406-23-000002

CIK 0001077183other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 6:01 PM ET

Size

11.0 KB

Accession

0001931406-23-000002

Insider Transaction Report

Form 4
Period: 2023-06-01
Sikri Vishal
President and CCO, Inivata
Transactions
  • Tax Payment

    Common Stock

    2023-06-0121,406127,716 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $8.42Exp: 2029-06-01Common Stock (319,112 underlying)
    319,112
  • Restricted Stock Unit

    Exercise: $0.00Common Stock (21,204 underlying)
    21,204
  • Stock Option (Right to Buy)

    Exercise: $19.65Exp: 2030-05-11Common Stock (39,683 underlying)
    39,683
  • Performance Stock Unit

    Exercise: $0.00From: 2026-05-11Common Stock (21,204 underlying)
    21,204
Footnotes (7)
  • [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the June 1, 2023 vesting of restricted stock.
  • [F2]On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
  • [F3]On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F4]On May 11, 2023, Mr. Sikri was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F5]On May 11, 2023, Mr. Sikri was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
  • [F6]Once vested, the shares of common stock are not subject to expiration.
  • [F7]On May 11, 2023, Mr. Sikri was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001931406

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:01 PM ET
Size
11.0 KB